Welcome to our dedicated page for Gatx SEC filings (Ticker: GATX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Deciphering how railcar lease rates, residual values, and maintenance expenses flow through GATX’s financials can feel overwhelming. Each 10-K details hundreds of pages on fleet age profiles and segment earnings, while every 8-K may announce a multi-million-dollar tanker purchase or impairment. If tracking this information—or knowing when executives file Form 4s—costs you hours, you’re not alone.
Stock Titan’s AI reads GATX’s disclosures the moment they hit EDGAR and delivers plain-English takeaways. Instantly surface what matters in a GATX quarterly earnings report 10-Q filing, follow GATX insider trading Form 4 transactions in real time, and see which sections of the proxy statement spell out executive compensation. Our platform pairs AI-powered summaries with full documents so you can toggle between quick insight and deep dive, all while real-time alerts flag new 8-K material events explained clearly.
- GATX annual report 10-K simplified—fleet size, utilization, residual risk
- GATX Form 4 insider transactions real-time—who bought or sold stock today
- GATX earnings report filing analysis—segment margins and lease-rate trends
- Understanding GATX SEC documents with AI—no accounting degree required
- GATX proxy statement executive compensation—pay structure and incentives
Whether you’re modeling cash flows, monitoring covenant triggers, or simply checking GATX executive stock transactions Form 4 before the next dividend announcement, you’ll find every filing in one place—complete, searchable, and already explained.
Liquidia Corporation (Nasdaq: LQDA) filed a Form 8-K announcing the appointment of Dana Boyle as Chief Accounting Officer effective July 1, 2025. Boyle, 41, has led the company’s accounting function since January 2021 as SVP-Finance and Controller. Her background includes senior finance roles at Aerami Therapeutics and Aralez Pharmaceuticals, plus public-accounting experience at Deloitte & Touche. She is a licensed CPA (NY) and holds a B.S. in Accounting from Rutgers University.
Compensation package:
- Annual base salary: $425,000
- Target cash bonus: 50 % of base salary
- Equity award: Restricted Stock Units valued at $300,000 on the effective date. Vesting schedule: 25 % on July 11, 2026; remaining 75 % in equal quarterly installments over the following three years, subject to continued employment.
Severance terms: Under the Amended & Restated Executive Severance and Change in Control Plan, Boyle is entitled to up to 12 months of salary continuation, COBRA premium payments, and—if terminated within a change-in-control period—accelerated vesting of 100 % of unvested equity plus target bonus payout.
The filing states that no family relationships or related-party transactions exist. The appointment was not made pursuant to any arrangement with other parties.
Investor take-away: While the event does not directly influence revenue or near-term financials, installing a seasoned CAO may enhance financial reporting quality and internal controls—an incremental positive for governance‐focused investors.